Details of the Drug

General Information of Drug (ID: DM2DWUQ)

Drug Name

5-Nonyl-5-phenyl-imidazolidine-2,4-dione

Synonyms

CHEMBL39043

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

#Ro5 Violations (Lipinski): 1

Molecular Weight (mw)

302.4

Logarithm of the Partition Coefficient (xlogp)

5.1

Rotatable Bond Count (rotbonds)

9

Hydrogen Bond Donor Count (hbonddonor)

2

Hydrogen Bond Acceptor Count (hbondacc)

2

Chemical Identifiers

Formula: C18H26N2O2
IUPAC Name: 5-nonyl-5-phenylimidazolidine-2,4-dione
Canonical SMILES: CCCCCCCCCC1(C(=O)NC(=O)N1)C2=CC=CC=C2
InChI: InChI=1S/C18H26N2O2/c1-2-3-4-5-6-7-11-14-18(15-12-9-8-10-13-15)16(21)19-17(22)20-18/h8-10,12-13H,2-7,11,14H2,1H3,(H2,19,20,21,22)
InChIKey: YDNZJQWFOGASIE-UHFFFAOYSA-N

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Sodium channel unspecific (NaC)	TTRK8B9	NOUNIPROTAC	Inhibitor	[1]
Voltage-gated sodium channel alpha Nav1.3 (SCN3A)	TTAXZ0K	SCN3A_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	Comparative molecular field analysis of hydantoin binding to the neuronal voltage-dependent sodium channel. J Med Chem. 1999 May 6;42(9):1537-45.